• Media type: E-Article
  • Title: Management of Preschool Wheezing: Guideline from the Emilia-Romagna Asthma (ERA) Study Group
  • Contributor: Fainardi, Valentina; Caffarelli, Carlo; Deolmi, Michela; Skenderaj, Kaltra; Meoli, Aniello; Morini, Riccardo; Bergamini, Barbara Maria; Bertelli, Luca; Biserna, Loretta; Bottau, Paolo; Corinaldesi, Elena; De Paulis, Nicoletta; Dondi, Arianna; Guidi, Battista; Lombardi, Francesca; Magistrali, Maria Sole; Marastoni, Elisabetta; Pastorelli, Silvia; Piccorossi, Alessandra; Poloni, Maurizio; Tagliati, Sylvie; Vaienti, Francesca; Gregori, Giuseppe; Sacchetti, Roberto; [...]
  • Published: MDPI AG, 2022
  • Published in: Journal of Clinical Medicine, 11 (2022) 16, Seite 4763
  • Language: English
  • DOI: 10.3390/jcm11164763
  • ISSN: 2077-0383
  • Origination:
  • Footnote:
  • Description: Preschool wheezing should be considered an umbrella term for distinctive diseases with different observable and measurable phenotypes. Despite many efforts, there is a large gap in knowledge regarding management of preschool wheezing. In order to fill this lack of knowledge, the aim of these guidelines was to define management of wheezing disorders in preschool children (aged up to 5 years). A multidisciplinary panel of experts of the Emilia-Romagna Region, Italy, addressed twelve different key questions regarding the management of preschool wheezing. Clinical questions have been formulated by the expert panel using the PICO format (Patients, Intervention, Comparison, Outcomes) and systematic reviews have been conducted on PubMed to answer these specific questions, with the aim of formulating recommendations. The GRADE approach has been used for each selected paper, to assess the quality of the evidence and the degree of recommendations. These guidelines represent, in our opinion, the most complete and up-to-date collection of recommendations on preschool wheezing to guide pediatricians in the management of their patients, standardizing approaches. Undoubtedly, more research is needed to find objective biomarkers and understand underlying mechanisms to assess phenotype and endotype and to personalize targeted treatment.
  • Access State: Open Access